The US CAR-T Cell Therapy Market is experiencing exceptional growth due to increasing adoption of personalized cancer treatments, rising incidence of hematological malignancies, and strong investments in cell and gene therapy research. The United States remains a global leader in CAR-T therapy development, supported by advanced healthcare infrastructure, favorable regulatory pathways, and the...